Titel

Merkliste
1 Ergebnisse

Durable response to palbociclib and letrozole in ovarian ca..:

Frisone, D ; Charrier, M ; Clement, S...
info:eu-repo/semantics/altIdentifier/doi/10.1080/15384047.2019.1685291. , 2020

Link: https://serval.unil.ch/notice/serval:BIB_DDF548EFECDC

RT Journal
T1 <Title>Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivlausanne:oai:serval.unil.ch:BIB_DDF548EFECDC&Exemplar=1&LAN=DE
				
A1 Frisone, D
A1 Charrier, M
A1 Clement, S
A1 Christinat, Y
A1 Thouvenin, L
A1 Homicsko, K
A1 Michielin, O
A1 Bodmer, A
A1 Chappuis, P.O
A1 McKee, T.A
A1 Tsantoulis, P
YR 2020
K1 Antineoplastic Combined Chemotherapy Protocols/therapeutic use
K1 Biomarkers
K1 Tumor/genetics
K1 Cyclin E/genetics
K1 Cyclin-Dependent Kinase Inhibitor p16/genetics
K1 Cystadenocarcinoma
K1 Serous/drug therapy
K1 Serous/genetics
K1 Serous/pathology
K1 Female
K1 Gene Amplification
K1 Humans
K1 Letrozole/administration & dosage
K1 Middle Aged
K1 Neoplasm Recurrence
K1 Local/drug therapy
K1 Local/genetics
K1 Local/pathology
K1 Oncogene Proteins/genetics
K1 Ovarian Neoplasms/drug therapy
K1 Ovarian Neoplasms/genetics
K1 Ovarian Neoplasms/pathology
K1 Piperazines/administration & dosage
K1 Prognosis
K1 Pyridines/administration & dosage
K1 Retinoblastoma Binding Proteins/genetics
K1 Sequence Deletion
K1 Ubiquitin-Protein Ligases/genetics
K1 CDK4/6 inhibitors
K1 CDKN2A loss
K1 Ovarian cancer
K1 palbociblib
K1 precision oncology
JF info:eu-repo/semantics/altIdentifier/doi/10.1080/15384047.2019.1685291
LK http://dx.doi.org/https://serval.unil.ch/notice/serval:BIB_DDF548EFECDC
DO https://serval.unil.ch/notice/serval:BIB_DDF548EFECDC
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)